Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Clinical Nutrition Market
Clinical Nutrition Market Size
Clinical Nutrition Market size was valued at over USD 50.5 billion in 2022. Driven by the growing occurrence of metabolic disorders and numerous other chronic conditions worldwide, the market is expected to grow at over 10% CAGR from 2023 to 2032.
Surging prevalence of chronic conditions such as respiratory diseases, cardiovascular ailments, cancer, gastrointestinal disorders, and malnourishment among adults and children is elevating the need for nutritional support. Oropharyngeal dysphagia, while commonly observed among the geriatric population, is often also reported in patients suffering from neurological diseases such as multiple sclerosis, oropharyngeal dysphagia, Parkinson's disease, and dementia.
The swallowing problems caused by the condition are creating a strong impetus for clinical nutrition, especially as the disease load of neurological disorders continues to rise across the globe. As per a report published by WHO in 2022, the number of people suffering from dementia is likely to reach 78 million in 2030 and 139 million in 2050.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 50.5 billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 10% |
| 2032 Value Projection: | USD 128 billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 330 |
| Tables, Charts & Figures: | 679 |
| Segments covered: | Product, Consumer, Application, Distribution Channel, and Dosage Formulation |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Strict regulatory scenario may dampen the clinical nutrition market outlook
Strict regulations governing the clinical nutrition landscape may hold back the industry scenario through 2032. In the US, the FDA regulates clinical nutrition products under a different set of guidelines than those covering drug products and conventional food items. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA prohibits the sale of clinical nutrition products that are misbranded of adulterated in any way.
With patient lives on the line, manufacturers have to strictly adhere to the regulatory guidelines, and any type of alterations to the product compositions have to get approved by the governing body before commercialization can be commenced. This makes the cost of entry particularly high for newcomers in the sector.
Clinical Nutrition Market Analysis
Based on product, the clinical nutrition market size from enteral nutrition segment was valued at more than USD 17.1 billion in 2022. Increasing cases of pediatric gastrointestinal disorders across the globe are likely to outline the market scenario. Enteral nutrition is usually prescribed to patients with partially functioning gut to effectively fulfil their energy as well as nutrient requirements. Often people with gastrointestinal disorders are not able to meet their day-to-day nutrition requirements through regular food intake, making enteral feeding integral for their health. This type of clinical nutrition is efficacious in most cases of GI disorders due to its ability to deliver enhanced patient outcomes without many complications.
Based on consumer, clinical nutrition market from the pediatric consumer segment is slated to surpass USD 78.2 billion by 2032, driven by the surging prevalence of poverty and overpopulation in underdeveloped nations. Poverty and overpopulation is an unfortunate mix that often leads to malnourishment among children. As per the World Bank, more than 10 million people, approximately 41.8% of the population fell under the extreme poverty line in Niger, an underdeveloped West African country, in 2021.
Based on distribution channel, the retail stores segment held over 42% revenue share of the clinical nutrition market in 2022, driven primarily by the better availability of clinical nutrition products in retail stores. With growing brand awareness among potential consumers, the ease of access facilitated by retail outlets is allowing manufacturers to capitalize on the emerging market scenario. Many retail stores also conduct frequent nutritional awareness programs, and educational, and health screening initiatives to raise awareness in the community and address their health needs, further shaping the segment outlook.
Europe clinical nutrition market valuation is anticipated to surpass USD 30.5 billion by 2032, on account of the growing prevalence of cancer cases in the region. An increasing number of cancer patients in Europe suffering from nutritional deficiency. Apart from cancer, increasing occurrence of gastrointestinal, infectious, mechanical, and metabolic complications in the region is also creating a large consumer base for the market. U.S. Clinical Nutrition industry is expected to register over 9% CAGR from 2023 to 2032, due to the increasing incidence of chronic diseases.
Clinical Nutrition Market Share
The list of clinical nutrition market leaders includes names such as
- Mead Johnson (Rickett Benckiser)
- Royal DSM
- Nestle Health Science S.A.
- Abbott Laboratories
- Fresenius Kabi AG
- AYMES International Ltd
- Medifood International Ltd
Many players focus on product innovations to reinforce their industry leadership.
Impact of COVID-19 Pandemic
The COVID-19 pandemic asserted a drastic impact on the global clinical nutrition industry. The high COVID-19 patient load and death rates in the initial months of 2020 compelled people to avoid any other treatment at healthcare units. However, the industry started to recover post the initial COVID-19 spike due to the rollout of favorable programs. For example, in 2020, the American Society for Clinical Nutrition and Metabolism rolled out recommendations related to the nutritional portfolio of COVID-19 patients, which created a strong product demand. Also, in November 2022, the USDA invested more than USD 59 million to improve nutrition security in the nation.
The clinical nutrition market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
- Infant Nutrition
- Milk Based
- Soy Based
- Organic Formulas
- Others
- Enteral Nutrition
- Standard Composition
- Disease Specific Composition
- Parenteral Nutrition
- Amino Acids
- Fats
- Carbohydrates
- Others
By Consumer
- Pediatric
- Adult
By Application
- Cancer
- Metabolic Disorders
- Neurological Diseases
- Gastrointestinal Disorders
- Others
By Distribution Channel
- Retail Stores
- Pharmacies & Drug Stores
- Online Channels
- Others
By Dosage Formulation
- Powder
- Liquid
- Solid
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Switzerland
- Sweden
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Columbia
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Iran
- Egypt
- Israel
Frequently Asked Questions (FAQ) :